New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles

Current B-cell disorder treatments take advantage of dose-intensive chemotherapy regimens and immunotherapy via use of monoclonal antibodies. Unfortunately, they may lead to insufficient tumor distribution of therapeutic agents, and often cause adverse effects on patients. In this contribution, we p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mezzaroba, Nelly, Zorzet, Sonia, Secco, Erika, Biffi, Stefania, Tripodo, Claudio, Calvaruso, Marco, Mendoza-Maldonado, Ramiro, Capolla, Sara, Granzotto, Marilena, Spretz, Ruben, Larsen, Gustavo, Noriega, Sandra, Lucafò, Marianna, Mansilla, Eduardo, Garrovo, Chiara, Marín, Gustavo H., Baj, Gabriele, Gattei, Valter, Pozzato, Gabriele, Núñez, Luis, Macor, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787049/
https://www.ncbi.nlm.nih.gov/pubmed/24098639
http://dx.doi.org/10.1371/journal.pone.0074216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787049/
https://www.ncbi.nlm.nih.gov/pubmed/24098639
http://dx.doi.org/10.1371/journal.pone.0074216

Ejemplares similares